NCT05459870View on ClinicalTrials.gov

CAR-T Cells Targeting Autoimmune Diseases

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

June 30, 2026

Conditions
Autoimmune Diseases
Interventions
BIOLOGICAL

4SCAR T cells

Infusion of 4SCAR T cells at 10\^6 cells/kg body weight via IV

Trial Locations (2)

518000

RECRUITING

Shenzhen Geno-immune Medical Institute, Shenzhen

541000

RECRUITING

Guilin Hospital of Chinese Traditional and Western Medicine, Guilin

All Listed Sponsors
collaborator

Guilin Hospital of Chinese Traditional and Western Medicine

UNKNOWN

lead

Shenzhen Geno-Immune Medical Institute

OTHER